Información*
| Nombre | JULIO EDUARDO ROQUE MORAN ANDRADE |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | NEUROCIENCIAS |
| Especialidad | MUERTE |
| CVU | 5444 |
| Institución | |
|---|---|
| Dependencia | COORDINACION DE LA INVESTIGACION CIENTIFICA |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 3 |
| Vigencia | Inicio: 01/01/2022 |
| Fin: 31/12/2046 | |
| Categoría: | EXTENSION 15 AÑOS |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2026
- Tibolone Administration Is Associated with Enhanced Motor Recovery and Decreased Cell-Specific NOX2 and NOX4 Immunoreactivity in a Rat Model of Traumatic Spinal Cord Injury Brain Sciences
- NLRP3 Inflammasome Activation in Oxidative Stress: A Key Mechanism Driving Neuroinflammation Neuroimmunomodulation
- 2025
- Tibolone Improves Motor Recovery and Regulates Neuroinflammation and Gliosis in a Model of Traumatic Spinal Cord Injury International Journal of Molecular Sciences
- Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage CNS Neuroscience & Therapeutics
- 2024
- CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX‐2 Activity and Oxidative Stress CNS Neuroscience & Therapeutics